XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents

Journal of the American Chemical Society

Volumn 125, Issue 25, 2003, Pages 7524-7525

  Hall, Matthew D ^a   Foran, Garry J ^b   Mei, Zhang ^c   Beale, Philip J ^c   Hambley, Trevor W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN SYNCHROTRON   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PLATINUM COMPLEX;

ARTICLE; CANCER CELL; ENERGY; OVARY CANCER; OXIDATION; REDUCTION; TEMPERATURE; X RAY ABSORPTION NEAR EDGE SPECTROSCOPY; X RAY SPECTROMETRY;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; OXIDATION-REDUCTION; PLATINUM; SPECTROMETRY, X-RAY EMISSION; TUMOR CELLS, CULTURED;

EID: 0037532807     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0354770     Document Type: Article

References (22)

1. Johnson, N. P.; Butour, J.-L.; Villani, G.; Wimmer, F. L.; Defais, M.; Pierson, V.; Brabec, V. Prog. Clin. Biochem. Med. 1989, 10, 1-24.
2. Talman, E. G.; Kidani, Y.; Mohrmann, L.; Reedijk, J. Inorg. Chim. Acta 1998, 283, 251-255.
3. Hall, M. D.; Hambley, T. W. Coord. Chem. Rev. 2002, 232, 49-67.
4. Pendyala, L.; Greco, W.; Cowens, J. W.; Madajewicz, S.; Creaven, P. J. Cancer Chemother. Pharmacol. 1983, 11, 23-28.
5. Petros, W. P.; Chaney, S. G.; Smith, D. C.; Fangmeier, J.; Sakata, M.; Brown, T. D.; Trump, D. L. Cancer Chemother. Pharmacol. 1994, 33, 347-354.
6. Dillon, C. T.; Lay, P. A.; Cholewa, M.; Legge, G. J. F.; Bonin, A. M.; Collins, T. J.; Kostka, K. L.; Shea-McCarthy, G. Chem. Res. Toxicol. 1997, 10, 533-535.
7. Frank, P.; Carlson, R. M. K.; Carlson, E. J.; Hodgson, K. O. Coord. Chem. Rev. 2003, 237, 31-39.
8. Benazeth, S.; Ascone, I.; Dexpert, H.; Nguyen-Huy, D.; Viossat, B. In X-ray absorption fine structure; Hasnain, S. S., Ed.; Ellis Horwood Ltd: Chichester, 1991; pp 184-186.
9. Hitchcock, A. P.; Lock, C. J. L.; Pratt, W. M. C. Inorg. Chim. Acta 1982, 66, L45-L47.
10. Teo, B.-K.; Eisenberger, P.; Reed, J.; Barton, J. K.; Lippard, S. J. J. Am. Chem. Soc. 1978, 100, 3225-3227.
11. Mazid, M. A.; Sadler, P. J.; Razi, M. T.; Ismail, I. M.; Greaves, G. N. In Proceedings of the Symposium on the Role of Physics in Development; Dhaka, 1982; pp 80-83.
12. Behrens, B. C.; Hamilton, T. C.; Masuda, H.; Grotzinger, K. R.; Whang-Peng, J.; Louie, K. G.; Knutsen, T.; McKoy, W. M.; Young, R. C.; Ozols, R. F. Cancer Res. 1987, 47, 414-418.
13. Ellis, L. T.; Er, H. M.; Hambley, T. W. Aust. J. Chem. 1995, 48, 793-806.
14. Hall, M. D.; Dillon, C. T.; Zhang, M.; Beale, P.; Cai, Z.; Lai, B.; Stampfl, A. P. J.; Hambley, T. W. J. Biol. Inorg. Chem. In press.
15. Raynaud, F. I.; Kelland, L. R.; Odell, D. E. Br. J. Cancer 1996, 74, 380-386.
16. Chaney, S. G.; Gibbons, G. R.; Wyrick, S.; Podhasky, P. Cancer Res. 1991, 51, 969-973.
17. Pendyala, L.; Walsh, J. R.; Huq, M. M.; Arakali, A. V.; Cowens, J. W.; Creaven, P. J. Cancer Chemother. Pharmacol. 1989, 25, 15-18.
18. Platts, J. A.; Hibbs, D. A.; Hambley, T. W.; Hall, M. D. J. Med. Chem. 2001, 44, 472-474.
19. Dolman, R. C.; Deacon, G. B.; Hambley, T. W. J. Inorg. Biochem. 2002, 88, 260-267.
20. Battle, A. R. In Ph.D. Thesis, University of Sydney, Sydney, 2001, p 221.
21. Lemma, K.; Shi, T.; Elding, L. Inorg. Chem. 2000, 39, 1728-1734.
22. Pendyala, L.; Cowens, J. W.; Chheda, G. B.; Dutta, S. P.; Creaven, P. J. Cancer Res. 1988, 48, 3533-3536.